Related Experiment Video

Updated: Jun 17, 2026

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
07:38

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection

Published on: May 10, 2024

Pathogenic role of myeloperoxidase in acute pancreatitis

Serge Chooklin1, Andriy Pereyaslov, Ihor Bihalskyy

  • 1Department of Surgery, Medical University, Lviv, Ukraine. chooklin_serge@hotmail.com

Hepatobiliary & Pancreatic Diseases International : HBPD INT
|December 17, 2009
PubMed
Abstract

Insights

Myeloperoxidase (MPO) levels correlate with acute pancreatitis (AP) severity and inflammatory markers. Pentoxifylline treatment reduced MPO levels, suggesting its potential in managing severe AP.

Area of Science:

  • Biochemistry
  • Immunology
  • Gastroenterology

Background:

  • Myeloperoxidase (MPO) is linked to tissue damage in inflammatory conditions.
  • MPO's role in acute pancreatitis (AP) severity and progression is not well-understood.

Purpose of the Study:

  • To investigate the relationship between MPO blood levels and AP severity.
  • To analyze the time-course of MPO levels during AP.
  • To explore MPO's correlation with cytokine levels and complications.

Main Methods:

  • Studied 86 AP patients (48 mild, 38 severe) and 18 controls.
  • Measured serum MPO and cytokine levels using MPO-EIA and ELISA.
  • Correlated MPO levels with pancreatitis severity, time-course, and complications.

Main Results:

  • Highest MPO levels observed on day one in severe AP patients.
  • MPO levels decreased within three days in necrotizing pancreatitis.
  • Increased MPO associated with lung injury and purulent complications.
  • Pentoxifylline significantly reduced MPO levels, correlating with reduced proinflammatory cytokines.

Conclusions:

  • Serum MPO levels are dependent on AP severity and cytokine levels.
  • Pentoxifylline may improve treatment outcomes in severe AP management.

More Related Videos

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice06:35

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice

Published on: June 28, 2021

Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct07:10

Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct

Published on: April 1, 2022

Related Concept Videos

Acute Pancreatitis II: Pathophysiology01:21

Acute Pancreatitis II: Pathophysiology

The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
Acute Pancreatitis I: Introduction01:25

Acute Pancreatitis I: Introduction

Acute pancreatitis is the sudden inflammation of the pancreas caused by the early activation of digestive enzymes, leading to the autodigestion of pancreatic tissue. This results in local inflammation and, in severe cases, systemic complications.EtiologyUnderstanding the underlying causes is crucial, as identifying the etiology guides treatment and anticipates complications. Acute pancreatitis can be triggered by various factors, typically grouped into the following clinical categories.Biliary...
Acute Pancreatitis I: Introduction01:27

Acute Pancreatitis I: Introduction

Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...